A recent article in JAMA Neurology features a case report by a team of Mayo Clinic researchers that implies involvement of organs beyond the central nervous system in neuromyelitis optica spectrum disorders.
In Genetic Engineering & Biotechnology, David Smith, Ph.D., professor of laboratory medicine and pathology at the Mayo Clinic, discusses integrating and interpreting clinical genomics data.
A Mayo Clinic-led group of researchers has discovered three subgroups of a single type of non-Hodgkin lymphoma that have markedly different survival rates. These subgroups could not be differentiated by routine pathology but only with the aid of novel genetic tests, which the research team recommends giving to all patients with ALK-negative anaplastic large-cell lymphoma (ALCL).
In the MAY Q&A Column in CAP TODAY, results from a urine collection study, conducted by the Mayo Clinic Department of Laboratory Medicine and Pathology, were referenced to respond to a reader’s question.
There are several mosquito and tick-borne diseases that present a serious risk. While insect repellent is a good way to ward off disease-carrying insects, you may be making common bug spray mistakes. Read this post to learn more.
In the May issue of CAP TODAY, Minetta Liu, M.D., of the Department of Medical Oncology and the Department of Laboratory Medicine and Pathology at Mayo Clinic discusses the use of circulating tumor cell (CTC) enumeration in her clinical practice.
Update: Video interview with Dr. Baudhuin has been added. In the May issue of “Clinical Chemistry,” Dr. Linnea Baudhuin assesses the recent Food and Drug Administration’s order to 23andMe to cease its marketing of its Personal Genome Service (PGS) test.
The April issue of Clinical Lab Products features Raouf Nakhleh, M.D., a pathologist at the Mayo Clinic in Jacksonville, Fla., and his leadership of CAP’s CDC project to improve the impact of laboratory practice guidelines.
In the March issue of Science, Mayo Clinic’s Fergus Couch, Ph.D., was recognized for his participation in the article, “Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention.”
The February issue of Transfusion Journal, features James Stubbs’, M.D., Chair of the Mayo Clinic Division of Transfusion Medicine, article, “Wrapping our arms around the cost of transfusion therapy.”
Mayo Clinic and Mayo Medical Laboratories have signed a collaboration agreement with bioTheranostics to offer CancerTYPE ID® molecular cancer classification test, as part of its surgical pathology consultations, to aid in the management of patients with metastatic cancer.
A clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital indicates that a new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells. In a paper in the Sept. 26 issue of the New England Journal of Medicine, the researchers report that patients who took the drug CMX001 shortly after transplant were far less likely to develop cytomegalovirus (CMV) infection than were patients who took a placebo.